Found 556472 clinical trials
Sort by:
Youth Empowerment and Safety Intervention
Not Applicable
Not yet recruiting
- Conditions
- SuicideSelf-Injurious Behavior
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- Case Western Reserve University
- Target Recruit Count
- 60
- Registration Number
- NCT07214233
Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe
Not Applicable
Not yet recruiting
- Conditions
- Geographic Atrophy Secondary to Age-related Macular Degeneration
- Interventions
- Drug: APL-2, Pegcetacoplan
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- Apellis Pharmaceuticals, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT07214740
TCDS for the Treatment of Chronic Migraine
Not Applicable
Not yet recruiting
- Conditions
- Chronic Migraine HeadacheTranscranial Direct Current Stimulation
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- University College, London
- Target Recruit Count
- 20
- Registration Number
- NCT07214454
Evaluating the Feasibility and Preliminary Effects of BE+
Not Applicable
- Conditions
- Lung Cancer (Non-Small Cell)Self-management BehaviorPhysical ActivityStressQuality of LifeResistance Training
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- University of South Carolina
- Target Recruit Count
- 20
- Registration Number
- NCT07214441
- Locations
- 🇺🇸
University of South Carolina, Columbia, South Carolina, United States
Organoids for Bile Leaks
Not Applicable
Not yet recruiting
- Conditions
- Biliary Anastomosis Complication
- Interventions
- Biological: Organoid-guided treatment
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Target Recruit Count
- 25
- Registration Number
- NCT07214649
Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System
Not Applicable
Active, not recruiting
- Conditions
- Stem Cell Extraction After Blood Flow Restriction (BFR)
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- Andrews Research & Education Foundation
- Target Recruit Count
- 15
- Registration Number
- NCT07213726
- Locations
- 🇺🇸
Andrews Institute for Orthopaedics & Sports Medicine, Gulf Breeze, Florida, United States
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy
Not Applicable
Not yet recruiting
- Conditions
- Septic ShockCoagulopathy
- Interventions
- Drug: • Sivelestat intravenous infusionDrug: NaCl intravenous infusion
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- University Hospital, Strasbourg, France
- Target Recruit Count
- 120
- Registration Number
- NCT07214103
- Locations
- 🇫🇷
Hôpitaux Universitaires de Strasbourg, Strasbourg, France, France
Monoclonal Gammopathies
Active, not recruiting
- Conditions
- Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)Multiple Myeloma (MM)
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- Azienda USL Reggio Emilia - IRCCS
- Target Recruit Count
- 60
- Registration Number
- NCT07214324
- Locations
- 🇮🇹
Istituto Ortopedico Rizzoli IRCCS, Bologna, Italy
🇮🇹UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco", Catania, Italy
🇮🇹UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone", Palermo, Italy
Virtual Reality Treatment for Trauma Related to COVID-19 Infection
Not Applicable
Not yet recruiting
- Conditions
- PTSDPTSD Symptoms
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- Soonchunhyang University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT07213596
A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- Apellis Pharmaceuticals, Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT07213960
- Locations
- 🇺🇸
Investigator Site 1, Chicago, Illinois, United States
🇺🇸Investigator Site 2, New York, New York, United States